We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-8.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.07B
AUM Growth
-$732M
Cap. Flow
-$324M
Cap. Flow %
-7.96%
Top 10 Hldgs %
18.03%
Holding
679
New
46
Increased
261
Reduced
260
Closed
64

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$31.9M
2
MCK icon
McKesson
MCK
+$27.5M
3
PG icon
Procter & Gamble
PG
+$27.1M
4
SBUX icon
Starbucks
SBUX
+$27M
5
NVDA icon
NVIDIA
NVDA
+$21M

Sector Composition

Rank Sector Weight
1 Healthcare 28.72%
2 Financials 13.85%
3 Technology 10.05%
4 Consumer Discretionary 8.55%
5 Consumer Staples 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMS icon
326
CMS Energy
CMS
$23.1B
$2.06M 0.05%
58,256
-3,779
-6% -$127K
SIAL
327
DELISTED
SIGMA - ALDRICH CORP
SIAL
$2.05M 0.05%
14,773
-1,312
-8% -$183K
ACOR
328
DELISTED
Acorda Therapeutics
ACOR
$2.04M 0.05%
641
+41
+7% +$159K
INFI
329
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$2.04M 0.05%
240,900
-24,100
-9% -$222K
ZSPH
330
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$2.02M 0.05%
+30,750
New +$1.85M
EPZM
331
DELISTED
Epizyme, Inc
EPZM
$2.01M 0.05%
156,000
-6,000
-4% -$121K
UN
332
DELISTED
Unilever NV New York Registry Shares
UN
$2M 0.05%
+49,700
New +$2.09M
GG
333
DELISTED
Goldcorp Inc
GG
$1.98M 0.05%
158,659
-241,387
-60% -$3.37M
PTCT icon
334
PTC Therapeutics
PTCT
$6.37B
$1.98M 0.05%
74,000
+8,000
+12% +$342K
MACK
335
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1.96M 0.05%
29,284
+4,499
+18% +$367K
FOSL icon
336
Fossil Group
FOSL
$239M
$1.95M 0.05%
34,876
+16,446
+89% +$1.04M
KR icon
337
Kroger
KR
$34.8B
$1.94M 0.05%
53,717
-3,787
-7% -$140K
BAP icon
338
Credicorp
BAP
$30.9B
$1.93M 0.05%
18,100
-8,000
-31% -$967K
ISRG icon
339
Intuitive Surgical
ISRG
$121B
$1.92M 0.05%
37,611
+2,043
+6% +$116K
CERN
340
DELISTED
Cerner Corp
CERN
$1.9M 0.05%
31,682
+3,059
+11% +$200K
MFC icon
341
Manulife Financial
MFC
$72.6B
$1.9M 0.05%
123,281
-143,888
-54% -$2.41M
CAG icon
342
Conagra Brands
CAG
$7.07B
$1.89M 0.05%
60,001
+2,830
+5% +$95K
NFLX icon
343
Netflix
NFLX
$292B
$1.88M 0.05%
181,690
+12,430
+7% +$133K
DGX icon
344
Quest Diagnostics
DGX
$25.1B
$1.86M 0.05%
30,308
-70,005
-70% -$4.89M
TROW icon
345
T. Rowe Price
TROW
$25B
$1.86M 0.05%
26,732
+12,698
+90% +$941K
HAR
346
DELISTED
Harman International Industries
HAR
$1.85M 0.05%
19,275
-58,000
-75% -$6.09M
PAYX icon
347
Paychex
PAYX
$40.4B
$1.84M 0.05%
38,577
-62,911
-62% -$2.93M
COF icon
348
Capital One
COF
$124B
$1.8M 0.04%
24,841
-117,040
-82% -$9.4M
CTSH icon
349
Cognizant
CTSH
$21.5B
$1.79M 0.04%
28,657
-6,828
-19% -$429K
ERF
350
DELISTED
Enerplus Corporation
ERF
$1.76M 0.04%
363,756
+99,551
+38% +$631K

Similar funds

Candriam SCA's Q3 2015 Portfolio in Review

As of Q3 2015, Candriam SCA held 679 positions worth $4.07B, down 15% from $4.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $324M in Q3 2015, closing 64 positions and reducing 260 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in Masco worth $14.9M.

  • Candriam SCA's largest Q3 2015 buy was Masco: 593,671 shares worth $14.9M.
  • Candriam SCA added most to Nike in Q3 2015, an estimated $31.9M increase.
  • Candriam SCA's biggest Q3 2015 reduction was iShares US Real Estate ETF, cutting an estimated $31.3M.
  • Candriam SCA fully exited Alphabet (Google) Class C in Q3 2015, selling an estimated $109M.
  • Candriam SCA's ten largest holdings make up 18% of its $4.07B portfolio in Q3 2015.
  • Candriam SCA opened 46 new positions and closed 64 in Q3 2015.
  • Candriam SCA's portfolio value fell 15% quarter-over-quarter to $4.07B.

Based on Candriam SCA's 13F filing for Q3 2015, filed 19 Oct 2015.